Real-world outcomes with mepolizumab in patients with severe asthma and comorbid anxiety/depression: REALITI-A at 2 years

被引：1
|
作者：
Chaudhuri, Rekha [1 ]
Liu, Mark C. [2 ,3 ,4 ]
Bagnasco, Diego [5 ]
Matucci, Andrea [6 ]
Pilette, Charles [7 ,8 ]
Price, Robert G. [9 ]
Demetriou, Lydia [10 ]
Howarth, Peter [11 ]
机构：
[1] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
[2] Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD USA
[3] Johns Hopkins Asthma & Allergy Ctr, Div Pulm, Baltimore, MD USA
[4] Johns Hopkins Asthma & Allergy Ctr, Div Crit Care Med, Baltimore, MD USA
[5] Univ Genoa, Osped Policlin San Martino, DIMI Dept Internal Med, Allergy & Resp Dis, Genoa, Italy
[6] Univ Florence, Azienda Osped Univ Careggi, Immunoallergol Unit, Florence, Italy
[7] UCLouvain, Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
[8] UCLouvain, Inst Expt & Clin Res, Pole Pneumol ENT & Dermatol, Brussels, Belgium
[9] GSK, Biostat, Stevenage, Herts, England
[10] GSK, Value Evidence & Outcomes, Stevenage, Herts, England
[11] GSK, Specialty Care TA, Global Med, Brentford, Middx, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
Asthma-management; Immunology; Severe asthma;
D O I：
10.1183/13993003.congress-2023.PA4757
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid GERD or Anxiety/Depression: Post Hoc Analysis of REALITI-A
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Maxwell, Aoife
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Lee, Jason
    Cheema, Amarjit
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [2] The Influence of Administering Mepolizumab by Autoinjector on Real-world Outcomes in Severe Asthma: Results From the REALITI-A Study at 2 Years
    Liu, M. C.
    Pilette, C.
    Bagnasco, D.
    Audicana Berasategui, M. T.
    Smith, A.
    Price, R. G.
    Demetriou, L.
    Hill, D. G.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Real-world mepolizumab outcomes in severe asthma: REALITI-A post hoc analysis by exacerbation history
    Bagnasco, Diego
    Lougheed, Diane
    Subramanian, Vijay
    Clifton, Ian J.
    Price, Robert G.
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] The impact of mepolizumab self-administration on real-world outcomes in patients with severe asthma: Post hoc analysis of REALITI-A at 2 years
    Canonica, G. W.
    Demetriou, L.
    Schleich, F.
    Pelaia, G.
    Bernstein, D.
    Lee, F. E. H.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 185 - 186
  • [5] Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
    Harrison, Tim
    Canonica, Giorgio Walter
    Chupp, Geoffrey
    Lee, Jason
    Schleich, Florence
    Welte, Tobias
    Valero, Antonio
    Gemzoe, Kim
    Maxwell, Aoife
    Joksaite, Sandra
    Yang, Shibing
    Howarth, Peter
    Van Dyke, Melissa K.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [6] The impact of comorbid nasal polyps on real-world mepolizumab effectiveness in patients with severe asthma: Results from the REALITI-A study
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Maxwell, Aoife C.
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Yang, Shibing
    Howarth, Peter
    Cheema, Amarjit S.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [7] The Impact of Comorbid Nasal Polyps on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study
    Liu, M. C.
    Bagnasco, D.
    Matucci, A.
    Pilette, C.
    Price, R. G.
    Maxwell, A. C.
    Cristancho, R. Alfonso
    Jakes, R. W.
    Yang, S.
    Howarth, P.
    Cheema, A. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] National Differences in Real-World Outcomes with Mepolizumab Treatment for Patients with Severe Asthma: Results from the REALITI-A Study
    Lee, J. K.
    Schleich, F.
    Canonica, G. W.
    Munoz, X.
    Chaudhuri, R.
    Lee, F. E.
    Howarth, P.
    Price, R. G.
    Yang, S.
    Jakes, R. W.
    Maxwell, A.
    Cristancho, R. Alfonso
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Sanchez, Carlos Almonacid
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Maxwell, Aoife
    Price, Robert
    Howarth, Peter
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [10] Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years
    Smith, A.
    Patel, M.
    Caruso, C.
    Pilette, C.
    Welte, T.
    Alfonso-Cristancho, R.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 50 - 51
12345